Literature DB >> 22969847

Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis.

Kazuhiro Kotoh1, Marie Fukushima, Yuki Horikawa, Shinsaku Yamashita, Motoyuki Kohjima, Makoto Nakamuta, Munechika Enjoji.   

Abstract

Residual hepatic functional reserve in cirrhotic patients is generally evaluated by a multivariate scoring system (Child-Pugh classification), which includes serum albumin levels as a variable. However, several patients show discrepancies between serum albumin levels and the progression of liver fibrosis, especially those with alcoholic cirrhosis. To assess whether hepatic capacity of protein synthesis varies with the etiology of cirrhosis, serum albumin and cholinesterase levels, and prothrombin time were compared between alcoholic cirrhosis and hepatitis C virus (HCV)-related cirrhosis. To minimize the influence of malnutrition and extrahepatic platelet destruction, patients with hepatocellular carcinoma, uncontrolled diabetes, appetite loss and/or splenal longitudinal size >15 cm were excluded. The patients with compensated liver cirrhosis were divided into three groups as follows: alcohol(+)/HCV(+) (alcohol + HCV group; n=31), alcohol(-)/HCV(+) (HCV group; n=31) and alcohol(+)/HCV(-) (alcohol group; n=27). These groups were adjusted with respect to age, gender, body mass index and platelet count. Serum albumin levels in the alcohol group were significantly higher than those in the HCV group, with a difference of approximately 0.5 g/dl in every class of platelet count. The correlation of the alcohol + HCV group was intermediate between the alcohol and HCV groups. On the other hand, the correlations between serum cholinesterase levels and platelet counts were similar among the three groups. The prothrombin time was also comparable among the groups. Accordingly, serum albumin levels were higher in patients with alcoholic cirrhosis and alcohol consumption should be carefully considered when evaluating hepatic functional reserve.

Entities:  

Year:  2011        PMID: 22969847      PMCID: PMC3438811          DOI: 10.3892/etm.2011.370

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  15 in total

1.  Effects of an appropriate oral diet on the nutritional status of patients with HCV-related liver cirrhosis: a prospective study.

Authors:  F Manguso; G D'Ambra; A Menchise; R Sollazzo; L D'Agostino
Journal:  Clin Nutr       Date:  2005-04-07       Impact factor: 7.324

2.  Splenic blood flow and intrasplenic platelet kinetics in relation to spleen volume.

Authors:  H Wadenvik; I Denfors; J Kutti
Journal:  Br J Haematol       Date:  1987-10       Impact factor: 6.998

3.  The role of laparoscopy in the diagnosis of cirrhosis.

Authors:  J Poniachik; D E Bernstein; K R Reddy; L J Jeffers; M E Coelho-Little; F Civantos; E R Schiff
Journal:  Gastrointest Endosc       Date:  1996-06       Impact factor: 9.427

4.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Authors:  Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

Review 5.  How much liver resection is too much?

Authors:  Emma J Mullin; Matthew S Metcalfe; Guy J Maddern
Journal:  Am J Surg       Date:  2005-07       Impact factor: 2.565

6.  Albumin and collagen gene regulation in alcohol- and virus-induced human liver disease.

Authors:  G Annoni; F R Weiner; M Colombo; M J Czaja; M A Zern
Journal:  Gastroenterology       Date:  1990-01       Impact factor: 22.682

7.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Authors:  Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

8.  Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.

Authors:  Robert J Fontana; Zachary D Goodman; Jules L Dienstag; Herbert L Bonkovsky; Deepa Naishadham; Richard K Sterling; Grace L Su; Mita Ghosh; Elizabeth C Wright
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

9.  Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography.

Authors:  Chie Tatsumi; Masatoshi Kudo; Kazuomi Ueshima; Satoshi Kitai; Shunsuke Takahashi; Tatsuo Inoue; Yasunori Minami; Hobyung Chung; Kiyoshi Maekawa; Kenji Fujimoto; Tonomura Akiko; Mitake Takeshi
Journal:  Intervirology       Date:  2008-06-10       Impact factor: 1.763

10.  Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices.

Authors:  Dong Kyu Park; Soon Ho Um; Jae Won Lee; Jung Bok Lee; Young Sun Kim; Chul Hee Park; Yoon Tae Jin; Hoon Jai Chun; Hong Sik Lee; Sang Woo Lee; Jai Hyun Choi; Chang Duck Kim; Ho Sang Ryu; Jin Hai Hyun
Journal:  J Gastroenterol Hepatol       Date:  2004-09       Impact factor: 4.029

View more
  2 in total

1.  Liver functions in silica-exposed workers in Egypt: possible role of matrix remodeling and immunological factors.

Authors:  Nermin Zawilla; Fatma Taha; Yasser Ibrahim
Journal:  Int J Occup Environ Health       Date:  2014-03-24

2.  CLIF-SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis.

Authors:  Jin Hee Jeong; In Sung Park; Dong Hoon Kim; Seong Chun Kim; Changwoo Kang; Soo Hoon Lee; Tae Yun Kim; Sang Bong Lee
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.